CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

IDH1 R132 mutation

Gene: IDH1 · Type: mutation

Indications: Acute myeloid leukemia, Cholangiocarcinoma

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
IvosidenibAcute myeloid leukemia, CholangiocarcinomaINDICATED
FDA Label
Label
OlutasidenibAcute myeloid leukemia, CholangiocarcinomaINDICATED
FDA Label
Label